HLA-C and neoplasm: As an alternative to TEX treatment, DCs loaded with TEXs markedly foster anti‐tumor immunity responses, given that DCs provide natural costimulatory molecules, inflammatory cytokines, and abundant MHC molecules, which are usually insufficient for T cell activation on tumors.